Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Roche's MabThera approved for two vasculitis indications in UK
Guillain-Barré syndrome: clinical profile and management.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Risk factors for rare diseases can be risky to define: PML and natalizumab.
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
Centocor briefing document for Ustekinumab, submitted to FDA
Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically Active Disease
White matter astrocytes in health and disease.
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multipl
Remyelination therapy goes to trial for multiple sclerosis
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
[Plasmapheresis in central nervous system disorders].
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR.
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.

Pages